Published in J Mol Cell Cardiol on October 01, 1990
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (1987) 5.46
Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res (2000) 2.80
Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol (1970) 1.84
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol (2001) 1.83
Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A (1990) 1.82
Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst (1994) 1.81
The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol (1990) 1.76
Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci (1984) 1.67
Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res (1996) 1.65
Retrograde coronary venous infusion of ethanol for ablation of canine ventricular myocardium. J Cardiovasc Electrophysiol (1998) 1.63
Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development (1995) 1.53
Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res (1994) 1.52
Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer (1997) 1.50
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation. Cancer Biother Radiopharm (1999) 1.49
Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens. Biotech Histochem (1996) 1.44
Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab Invest (1984) 1.41
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol (1999) 1.35
Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation (1992) 1.33
Ultrastructural changes in the canine myocardium with right ventricular hypertrophy and congestive heart failure. Lab Invest (1969) 1.30
Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol (1998) 1.28
Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res (1999) 1.28
The success of a clinical librarian program in an academic autopsy pathology service. Am J Clin Pathol (1993) 1.27
The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol (2000) 1.26
Regional myocardial blood flow during acute myocardial infarction in the conscious dog. Circ Res (1976) 1.25
Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol (2001) 1.24
An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol (1999) 1.24
Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol (1997) 1.24
Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure. J Clin Invest (1992) 1.23
Combined effects of formalin fixation and tissue processing on immunorecognition. Biotech Histochem (2009) 1.22
Regional differences in myocyte size in normal rat heart. Anat Rec (1986) 1.21
Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol (2000) 1.19
Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer (1998) 1.18
Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl Immunohistochem Mol Morphol (2000) 1.18
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol (1997) 1.17
Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med (2000) 1.17
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther (2000) 1.17
Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'. Arch Pathol Lab Med (1989) 1.16
Myocardial necrosis, fibrosis, and DNA synthesis in experimental cardiac hypertrophy induced by sudden pressure overload. Circ Res (1976) 1.15
Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol (1982) 1.13
Exosomes and immune surveillance of neoplastic lesions: a review. Biotech Histochem (2012) 1.12
Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand J Immunol (2005) 1.12
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study. Gynecol Oncol (1997) 1.10
Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res (2000) 1.10
Cyclosporine reduces left ventricular mass with chronic aortic banding in mice, which could be due to apoptosis and fibrosis. J Mol Cell Cardiol (2001) 1.10
Establishing a tumour bank: banking, informatics and ethics. Br J Cancer (2004) 1.09
Special communication. The Cooperative Human Tissue Network. Cancer (1989) 1.09
Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control (2003) 1.08
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49. J Nucl Med (1996) 1.05
Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. Int J Cancer (2000) 1.05
Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study. Arch Pathol Lab Med (1988) 1.05
Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol (2001) 1.05
Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers. Mol Ther (2001) 1.05
Cellular mechanism of thymic involution. Scand J Immunol (2003) 1.04
Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res (1989) 1.04
Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Circ Res (1990) 1.03
The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol (2000) 1.03
Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res (1990) 1.02
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol (1995) 1.02
Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand J Immunol (2009) 1.02
Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation (1995) 1.01
Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol (1983) 1.01
Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas. Clin Cancer Res (2001) 0.99
Myocardial cell hypertrophy or hyperplasia. Hypertension (1985) 0.98
Experimental aortic intimal thickening. I. Morphology and source of intimal cells. Am J Pathol (1974) 0.98
Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma. J Urol (1995) 0.97
Regional myocyte size in normotensive and spontaneously hypertensive rats. Hypertension (1980) 0.97
Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation (1997) 0.96
Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1997) 0.96
Subendocardial ischemic myocardial lesions associated with severe coronary atherosclerosis. Am J Pathol (1980) 0.94
Localized folate and vitamin B-12 deficiency in squamous cell lung cancer is associated with global DNA hypomethylation. Nutr Cancer (2000) 0.94
Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation (1993) 0.94
Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol (1993) 0.93
Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab (1997) 0.93
The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol (2001) 0.92
Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay. Biotech Histochem (2000) 0.92
Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope (2001) 0.91
Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53. Ann Surg (2001) 0.91
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49. J Nucl Med (1994) 0.91
Surface morphology and cell size measurement of isolated rat cardiac myocytes. J Mol Cell Cardiol (1979) 0.91
Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications. J Clin Oncol (1997) 0.91
Adult human valve dimensions and their surgical significance. Am J Cardiol (1984) 0.90
Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder. Am J Surg Pathol (1985) 0.90
The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol (1994) 0.90
Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat. Circ Res (1990) 0.89
Transmural progression of morphologic changes during ischemic contracture and reperfusion in the normal and hypertrophied rat heart. Am J Pathol (1987) 0.89
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study. Cancer Biother Radiopharm (2001) 0.89
Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs. Circ Res (1991) 0.88
Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors. Cancer Res (2000) 0.88
Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development. Mol Cell Biochem (1991) 0.88
Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol (1993) 0.87
Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster. Am Rev Respir Dis (1988) 0.87
The efficient operation of the surgical pathology gross room. Biotech Histochem (2008) 0.87
Retracted Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc Natl Acad Sci U S A (1998) 0.87
Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs. Am J Physiol Heart Circ Physiol (2000) 0.87
Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma. Int J Cancer (1996) 0.87
Ineffective perfusion-contraction matching in conscious, chronically instrumented pigs with an extended period of coronary stenosis. Circ Res (1998) 0.87
Histologic variation in the skin lesions of the glucagonoma syndrome. Am J Surg Pathol (1986) 0.86
Regional myocyte size in compensated right ventricular hypertrophy in the ferret. J Mol Cell Cardiol (1985) 0.86